Abnormal mechanical properties of larger arteries in postmenopausal women with systemic lupus erythematosus

Lupus

Volumn 13, Issue 12, 2004, Pages 917-923

  Brodszki, Jana ^a   Bengtsson, C ^a   Lanne T ^b   Nived, O ^a   Sturfelt, G ^a   Marsal K ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Arteries; Atherosclerosis; SLE; Ultrasonography; Vascular disease

Indexed keywords

ABDOMINAL AORTA; ADULT; AGE DISTRIBUTION; AGED; ANKLE BRACHIAL INDEX; ANKLE PRESSURE; ARTERY; ARTICLE; ATHEROSCLEROSIS; B SCAN; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; FEMALE; HUMAN; MEAN ARTERIAL PRESSURE; MECHANOTRANSDUCTION; PATHOGENESIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; POSTMENOPAUSE; PREMATURE AGING; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RIGIDITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGE FACTORS; AGED; AORTA, ABDOMINAL; BLOOD PRESSURE; CAROTID ARTERY, COMMON; CASE-CONTROL STUDIES; ELASTICITY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; POPLITEAL ARTERY; POSTMENOPAUSE;

EID: 10844219743     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu2033oa     Document Type: Article

References (43)

1. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality in SLE. Am J Med 1976; 60: 221-225.
2. Ståhl-Hallengren C, Jönsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 2000; 3: 685-691.
3. Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine 1989; 68: 141-150.
4. Manzi S, Meilahn EN, Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 1997; 145: 408-415.
5. Manzi S, Selzer F, Sutton-Tyrell K et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999; 1: 51-60.
6. Sturfelt G, Eskilsson J, Nived O, Truedsson L, Valind S. Cardiovascular disease in systemic lupus erythematosus. Medicine 1992; 4: 216-223.
7. Petri M, Spence D, Bone LR, Hochberg MC. Coronary artery disease riskfactors in the John Hopkins lupus cohort: prevalence, recognition by patients, and preventive practices. Medicine 1992; 5: 291-302.
8. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 338-346.
9. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 11: 1271-1277.
10. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the system lupus international collaborating clinics/ American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 3: 363-369.
11. Sturfelt G, Nived O, Norberg R, Thorstensson R, Krook K. Anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1987; 30: 382-388.
12. Management of peripheral arterial disease (PAD) - Transatlantic intersociety consensus (TASC). Epidemiology, natural history, risk factors. Eur J Vasc Endovasc Surg 2000; 6: S5-S7.
13. Lindström K, Gennser G, Sindberg Eriksen P, Benthin M, Dahl P. An improved echo-tracker for studies on pulse waves in the fetal aorta. In Rolfe P ed. Fetal physiological measurements. London: Butterworths, 1987: 217-226.
14. Benthin M, Dahl P, Ruzicka R, Lindström K. Calculation of pulse-wave velocity using cross correlations - effects of reflexes in the arterial tree. Ultrasound Med Biol 1991; 17: 461-469.
15. Kawasaki T, Sasayama S, Yagi S, Asakawa T, Hirai T. Non-invasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovasc Res 1987; 21: 678-687.
16. Laurent S, Boutouyrie P, Asmar R et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
17. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998; 32: 570-574.
18. Hodes RJ, Lakatta EG, McNeil CT. Another modifiable risk factor for cardiovascular disease? Some evidence points to arterial stiffness. J Am Geriatr Soc 1995; 43: 581-582.
19. Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC study. Atherosclerosis risk in communities study. Circulation 1995; 91: 1432-1443.
20. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol 1994; 140: 669-682.
21. Farrar DJ, Bond MG, Riley WA, Sawyer JK. Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys. Circulation 1991; 83: 1754-1763.
22. Hirai T, Sasayama S, Kawasaki T, Yagi S. Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation 1989; 80: 78-86.
23. Nakashima T. Tanikawa J. A study of human aortic distensibility with relation to atherosclerosis and aging. Angiology 1971; 22: 477-490.
24. Riley WA, Evans GW, Sharrett AR, Burke GL, Barnes RW Variation of common carotid artery elasticity with intimal-medial thickness: the ARIC study. Atherosclerosis risk in communities. Ultrasound Med Biol 1997; 23: 157-164.
25. Megnien JL, Simon A, Denarie N et al. Aortic stiffening does not predict coronary and extracoronary atherosclerosis in asymptomatic men at risk for cardiovascular disease. Am J Hypertens 1998; 11(Pt 1); 293-301.
26. Nichols W, O'Rourke MF. Atherosclerosis. In Nichols W, O'Rourke MF eds. McDonald's blood flow in arteries, 4th edn. London: Edward Arnold, 1998: 400-401.
27. Rabinovitch M. Elastase and cell matrix interactions in the pathobiology of vascular disease. Acta Paediat Japon 1995; 37: 657-666.
28. Gminski J, Poborski W, Kasprzak A, Drozdz M, Kardaszewicz E, Machalski M. Anti-elastin antibodies in systemic lupus erythematosus. Pol Tyg Lek 1990; 45: 513-515.
29. Colburn KK, Sandberg LB, Malto M et al. Age-related circulating antibody levels to tropo- and alpha-elastin correlate with and are specific for their respective serum peptides in rats. J Invest Med 1995; 43: 284A.
30. Colburn KK, Langga-Shariffi E, Kelly GT et al. Abnormalities of serum antielastin antibodies in connective tissue diseases. J Invest Med 2003; 51: 104-109.
31. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-1321.
32. 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int 1995; 48: 844-850.
33. Selzer F, Sutton-Tyrrell K, Fitzgerald S, Tracy R, Kuller L, Manzi S. Vascular stiffness in women with systemic lupus erythematosus. Hypertension 2001; 37: 1075-1082.
34. Jiang CW, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. Br J Pharmacol 1991; 104: 1033-1037.
35. Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol 1994; 9: 619-626.
36. Magness RR, Rosenfield CR. Local and systemic estradiol 17-beta: effects on uterine and systemic vasodilatation. Am J Physiol 1989; 256: E536-E542.
37. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study. Arthritis Rheum 2002; 46: 1830-1839.
38. Bengtsson AA, Rylander L, Hagmar L, Nived O, Sturfelt G. Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology (Oxford) 2002; 41: 563-571.
39. Mok CC, Lau CS, Wong RW. Use of exogenous estrogens in systemic lupus erythematosus. Semin Arthritis Rheum 2001; 30: 426-435. (Erratum in Semin Arthritis Rheum 2001; 31: 142).
40. Mok CC, Lau CS, Wong RW. Use of exogenous estrogens in systemic lupus erythematosus. Semin Arthritis Rheum 2001; 30: 426-435. (Erratum in Semin Arthritis Rheum 2001; 31: 142).
41. Buyon JP, Petri M, Kim M et al. Estrogen/cyclic progesterone replacement is associated with and increased rate of mild/moderate but not severe flares in SLE patients in the SELENA trial. Arthritis Rheum 2003; 48(LB10): 3659.
42. Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus 2000; 9: 170-175.
43. Roman MJ, Shanker BA, Davis A et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2399-2406.